ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.3399T>C (p.Thr1133=)

gnomAD frequency: 0.00005  dbSNP: rs61748084
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000162415 SCV000212754 likely benign Hereditary cancer-predisposing syndrome 2014-08-26 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Counsyl RCV000409777 SCV000487809 likely benign Lynch syndrome 5 2015-11-17 criteria provided, single submitter clinical testing
Invitae RCV000458051 SCV000561535 likely benign Hereditary nonpolyposis colorectal neoplasms 2024-01-28 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000162415 SCV000690349 likely benign Hereditary cancer-predisposing syndrome 2016-04-04 criteria provided, single submitter clinical testing
GeneDx RCV000610158 SCV000729047 benign not specified 2015-05-21 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000610158 SCV000919734 likely benign not specified 2019-08-02 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000162415 SCV002528018 likely benign Hereditary cancer-predisposing syndrome 2021-08-17 criteria provided, single submitter curation
Myriad Genetics, Inc. RCV000409777 SCV004018881 benign Lynch syndrome 5 2023-03-28 criteria provided, single submitter clinical testing This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001357664 SCV004563598 likely benign not provided 2023-11-22 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV003998542 SCV004835064 likely benign Lynch syndrome 2023-12-13 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001357664 SCV001553194 likely benign not provided no assertion criteria provided clinical testing The MSH6 p.Thr1133= variant was not identified in the literature nor was it identified in the UMD-LSDB database. The variant was identified in dbSNP (ID: rs61748084) as "With Likely benign allele", and in ClinVar (classified as benign by GeneDx; as likely benign by Invitae, Ambry Genetics, Counsyl and Color). The variant was identified in control databases in 9 of 277182 chromosomes at a frequency of 0.00003 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 1 of 24036 chromosomes (freq: 0.00004), Latino in 1 of 34408 chromosomes (freq: 0.00003), European in 7 of 126686 chromosomes (freq: 0.00006); it was not observed in the Other, Ashkenazi Jewish, East Asian, Finnish, and South Asian populations. The p.Thr1133= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.